Statins: a repurposed drug to fight cancer.
Jiang W, Hu JW, He XR, Jin WL, He XY. · 2021
Read Statins: a repurposed drug to fight cancer. by Jiang W, Hu JW, He XR, Jin WL, He XY. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8306262.txt.
Description
Jiang and co-authors assess statins as a repurposed drug class against cancer. Statins block HMG-CoA reductase and lower cholesterol. Their wider effects reach beyond lipid control.
Anti-cancer action ranks among those extra effects. Many clinical and population studies report protective signs. Yet the evidence does not agree across the board. Some cancer subtypes may be far more open to statins than others. The review sorts the trial and cohort record. It asks which patients, if any, should get statins for cancer. The question stays open and active. Molecular subtypes may decide who gains from treatment.
Catalog record
| CREATOR | Jiang W, Hu JW, He XR, Jin WL, He XY. |
|---|---|
| YEAR | 2021 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 135 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |